Physician

Aaron David Doheny, APRN

According to 2025 Medicare claims, Aaron Doheny, APRN (NPI: 1730532854) practices nurse practitioner in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 33707-4505.

Doheny's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 12 traditional Medicare patients, billed 650 HCPCS/CPT codes, and received $8,527 in Medicare payments. Part D data shows 522 prescription claims across 187 beneficiaries totaling $1,097,596 in drug costs, led by Revlimid (Lenalidomide). Open Payments data shows 180 records totaling $4,768. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $14,445 to $1,097,596. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$21K$42K2023 Medicare payment: $42,303 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $8,527 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20231582,970$42,303
202412650$8,527

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$549K$1.1M2016 Drug cost: $14,445 (USD; Tot_Drug_Cst)2017 Drug cost: $23,441 (USD; Tot_Drug_Cst)2018 Drug cost: $172,036 (USD; Tot_Drug_Cst)2019 Drug cost: $113,903 (USD; Tot_Drug_Cst)2020 Drug cost: $117,621 (USD; Tot_Drug_Cst)2021 Drug cost: $303,790 (USD; Tot_Drug_Cst)2022 Drug cost: $504,683 (USD; Tot_Drug_Cst)2023 Drug cost: $626,131 (USD; Tot_Drug_Cst)2024 Drug cost: $1,097,596 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20163059$14,445
201793207$23,441
2018108296$172,036
2019127290$113,903
2020106285$117,621
202192239$303,790
2022121318$504,683
2023168486$626,131
2024187522$1,097,596

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Part B summary data is connected for 2024, but public code-level payment amounts are not available, so a Top 5 by total payments cannot be shown.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide19511$319,877
EliquisApixaban371,350$24,798
XareltoRivaroxaban15990$18,440
AnastrozoleAnastrozole836,811$1,258
HydroxyureaHydroxyurea332,225$709

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.180$4,768Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Aaron David Doheny, APRN?

Tedicare shows public-source Medicare data for Aaron David Doheny, APRN (NPI 1730532854), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron David Doheny, APRN have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aaron David Doheny, APRN?

Aaron David Doheny, APRN is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Aaron David Doheny, APRN have Open Payments data?

Aaron David Doheny, APRN has 180 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.